Tender Details
| Particulars | Details |
|---|---|
| Title |
Inj Novoseven 2 Mg L00 Kiu With Infusion Kl T (Eptacog Alfa Activated, Human Recombinant Coagulation Factor Vii Activated , R Dna Origin,2 Rng (100 Kiu) To Be Used With Reconstitution Solvent (Prefilled Syringe)and Infusion Kit.
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106545664 |
|
Reference Number |
61242930C |
| Tender Fee | 0 |
| EMD | 99060 |
| Tender Value | |
| Place | Mumbai CST |
| Link | https://www.ireps.gov.in/ireps/supply/pdfdocs/012025/106545664/viewNitPdf_4804057.pdf |
| Start Date | December 12, 2024 22:40 |
| End Date |
21/01/2025 ( Expired 108 days ago ) Search Similar tenders? |
|
Join for More Relevant Opportunities |
Inj human coagulation factor vii a 2 mg ( 100 kiu )
For complete deion and other details, please refer to tender
Read moreInj novoseven 2 mg l00kiu with infusion klt (eptacog alfa activated, human recombinant coagulation factor vii activated , rdna origin,2 rng (100 kiu) to be used with reconstitution solvent (prefilled syringe)and infusion kit.
For complete deion and other details, please refer to tender
Read moreInj human coagulation factor vii a 2 mg ( 100 kiu )
For complete deion and other details, please refer to tender
Read moreInj human coagulation factor vii a 2 mg ( 100 kiu )
For complete deion and other details, please refer to tender
Read more(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
Read more(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
Read more(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
Read more(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
Read more(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensur
For complete deion and other details, please refer to tender
Read more(ph no.: 49100) human growth hormone injection should have following specification: 1. should contain somatotropin recombinant dna origin. 2. should be prefilled, pre-loaded, flex pro pen with no need of external reconstitution. 3. minimum 15 n s of 36g disposable needles for subcutaneous use, should be supplied with each pen. 4. growth charts for follow up of the patients who are on therapy should be provided. 5. should demonstrate the product and ease of administration. 6. should ensu
For complete deion and other details, please refer to tender
Read moreof your Industry type